Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bryant

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Advances in Radiation Oncology|May 23, 2024
Novel Definitive Hypofractionated Accelerated Radiation Dose-painting (HARD) for Unresected Soft Tissue SarcomasJohn Michael Bryant, Matthew N Mills, George Q Yang, et al.
Cancers|April 13, 2023
Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future DirectionsJohn Michael Bryant, Joseph Weygand, Emily Keit, et al.
Plos Pathogens|July 8, 2021
Listeria monocytogenes infection rewires host metabolism with regulatory input from type I interferonsDuygu Demiroz, Ekaterini Platanitis, Michael Bryant, et al.
ACS Chemical Biology|January 29, 2015
Computational design and experimental characterization of peptides intended for pH-dependent membrane insertion and pore formationYao Zhang, René Bartz, Gevorg Grigoryan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2024
Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcomaJohn Michael Bryant, Matthew N Mills, Casey Liveringhouse, et al.
Cancers|November 14, 2023
Treatment of Central Nervous System Tumors on Combination MR-Linear Accelerators: Review of Current Practice and Future DirectionsJohn Michael Bryant, Ajay Doniparthi, Joseph Weygand, et al.
Human Molecular Genetics|June 23, 2007
Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) geneMasashi Demura, Regina M Martin, Makio Shozu, et al.
Diseases (Basel, Switzerland)|April 25, 2025
Leukocyte Dysregulation and Biochemical Alterations in End-Stage Kidney Disease Patients Under HemodialysisGabriela Goyoneche Linares, Daysi Zulema Diaz-Obregón, Ana Granda Alacote, et al.
Biomedicines|January 25, 2025
T-Cell Subpopulations and Differentiation Bias in Diabetic and Non-Diabetic Patients with Chronic Kidney DiseaseAna Cecilia Granda Alacote, Gabriela Goyoneche Linares, María Gracia Castañeda Torrico, et al.
Plos One|October 31, 2025
Variability of the lymphocyte-to-monocyte ratio in patients with chronic kidney disease on hemodialysisDaysi Zulema Diaz-Obregón, Gabriela Goyoneche Linares, Ana Granda Alacote, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Advances in Radiation Oncology|May 23, 2024
Novel Definitive Hypofractionated Accelerated Radiation Dose-painting (HARD) for Unresected Soft Tissue SarcomasJohn Michael Bryant, Matthew N Mills, George Q Yang, et al.
Cancers|April 13, 2023
Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future DirectionsJohn Michael Bryant, Joseph Weygand, Emily Keit, et al.
Plos Pathogens|July 8, 2021
Listeria monocytogenes infection rewires host metabolism with regulatory input from type I interferonsDuygu Demiroz, Ekaterini Platanitis, Michael Bryant, et al.
ACS Chemical Biology|January 29, 2015
Computational design and experimental characterization of peptides intended for pH-dependent membrane insertion and pore formationYao Zhang, René Bartz, Gevorg Grigoryan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 21, 2024
Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcomaJohn Michael Bryant, Matthew N Mills, Casey Liveringhouse, et al.
Cancers|November 14, 2023
Treatment of Central Nervous System Tumors on Combination MR-Linear Accelerators: Review of Current Practice and Future DirectionsJohn Michael Bryant, Ajay Doniparthi, Joseph Weygand, et al.
Human Molecular Genetics|June 23, 2007
Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) geneMasashi Demura, Regina M Martin, Makio Shozu, et al.
Diseases (Basel, Switzerland)|April 25, 2025
Leukocyte Dysregulation and Biochemical Alterations in End-Stage Kidney Disease Patients Under HemodialysisGabriela Goyoneche Linares, Daysi Zulema Diaz-Obregón, Ana Granda Alacote, et al.
Biomedicines|January 25, 2025
T-Cell Subpopulations and Differentiation Bias in Diabetic and Non-Diabetic Patients with Chronic Kidney DiseaseAna Cecilia Granda Alacote, Gabriela Goyoneche Linares, María Gracia Castañeda Torrico, et al.
Plos One|October 31, 2025
Variability of the lymphocyte-to-monocyte ratio in patients with chronic kidney disease on hemodialysisDaysi Zulema Diaz-Obregón, Gabriela Goyoneche Linares, Ana Granda Alacote, et al.
Pageof 5